Chicago, IL, United States of America

Guangxu Lan

USPTO Granted Patents = 2 

Average Co-Inventor Count = 3.7

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2020-2023

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Guangxu Lan in Photodynamic Therapy

Introduction

Guangxu Lan is a prominent inventor based in Chicago, IL, known for his significant contributions to the field of photodynamic therapy. He has been awarded two patents that focus on advanced materials for medical applications, particularly in cancer treatment.

Latest Patents

His latest patents include innovations in nanoscale metal-organic layers and metal-organic nanoplates designed for X-ray induced photodynamic therapy, radiotherapy, radiodynamic therapy, chemotherapy, immunotherapy, and their combinations. The patents describe metal-organic layers (MOLs) and metal-organic nanoplates (MOPs) that incorporate photosensitizers and moieties capable of absorbing X-rays or other ionizing irradiation energy. These innovations also explore methods of utilizing MOLs and MOPs in various therapeutic contexts, either alone or in conjunction with other therapeutic agents.

Career Highlights

Guangxu Lan is affiliated with the University of Chicago, where he conducts research and develops his innovative technologies. His work is pivotal in advancing treatment methodologies that leverage the unique properties of metal-organic frameworks (MOFs) and nanoparticles in medical applications.

Collaborations

He collaborates with notable researchers such as Wenbin Lin and Kaiyuan Ni, contributing to a dynamic research environment that fosters innovation in therapeutic technologies.

Conclusion

Guangxu Lan's work exemplifies the intersection of innovation and healthcare, showcasing how advanced materials can enhance treatment options for patients. His contributions are paving the way for future advancements in photodynamic therapy and related fields.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…